Thyrocare Technologies Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Lypsa Gems & Jewellery Ltd, S H Kelkar & Company Ltd, U. H. Zaveri Ltd and Zenith Exports Ltd are among the other losers in the BSE's 'B' group today, 07 January 2025.

Thyrocare Technologies Ltd tumbled 7.31% to Rs 943.5 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 24826 shares were traded on the counter so far as against the average daily volumes of 4298 shares in the past one month.

Lypsa Gems & Jewellery Ltd crashed 6.41% to Rs 7.15. The stock was the second biggest loser in 'B' group.On the BSE, 7988 shares were traded on the counter so far as against the average daily volumes of 20141 shares in the past one month.

S H Kelkar & Company Ltd lost 6.23% to Rs 231.95. The stock was the third biggest loser in 'B' group.On the BSE, 44086 shares were traded on the counter so far as against the average daily volumes of 11558 shares in the past one month.

U. H. Zaveri Ltd plummeted 4.99% to Rs 14.27. The stock was the fourth biggest loser in 'B' group.On the BSE, 1.29 lakh shares were traded on the counter so far as against the average daily volumes of 2.97 lakh shares in the past one month.

Zenith Exports Ltd shed 4.98% to Rs 266. The stock was the fifth biggest loser in 'B' group.On the BSE, 52 shares were traded on the counter so far as against the average daily volumes of 93 shares in the past one month.

Powered by Capital Market - Live News

Revenue from operations grew by 19.99% year on year (YoY) to Rs 177.36 crore in the quarter ended 30 September 2024.

Profit before tax in Q2 FY25 stood at Rs 36.78 crore, up 30.10% as against Rs 28.27 crore posted in same quarter last year.

Total expenses rose 16.88% YoY to Rs 142.90 crore during the quarter. Cost of materials and services consumed was at Rs 50.12 crore (up 16.34% YoY) while employee benefits expense stood at Rs 29.49 crore (up 8.98%) during the period under review.

The company's revenue from Diagnostic Testing Services was at Rs 161.92 crore (up 18.40% YoY) while revenue from Imaging Services stood at Rs 14.15 crore (up 20.83% YoY) in Q1 FY25.

EBITDA improved 28% YoY to Rs 48.2 crore in September 2024 quarter from Rs 37.6 crore reported in corresponding period previous year. EBITDA margin increased to 27% in Q2 FY25 as compared to 25% reported in the corresponding quarter last fiscal.

On half year basis, the company’s net profit jumped 35.06% to Rs 50.84 crore on 18.16% rise in revenue to Rs 334.27 crore in H1 FY25 over H1 FY24.

Thyrocare Technologies is engaged in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

The counter has hit a 52-week high at Rs 957.95 in today's intra-day session.

Powered by Capital Market - Live News

Net profit of Thyrocare Technologies rose 31.12% to Rs 26.67 crore in the quarter ended September 2024 as against Rs 20.34 crore during the previous quarter ended September 2023. Sales rose 19.84% to Rs 177.36 crore in the quarter ended September 2024 as against Rs 148.00 crore during the previous quarter ended September 2023.

Powered by Capital Market - Live News

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 23 October 2024.

Powered by Capital Market - Live News